0001140361-17-027822.txt : 20170713
0001140361-17-027822.hdr.sgml : 20170713
20170713173915
ACCESSION NUMBER: 0001140361-17-027822
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170712
FILED AS OF DATE: 20170713
DATE AS OF CHANGE: 20170713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioRestorative Therapies, Inc.
CENTRAL INDEX KEY: 0001505497
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 911835664
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MARCUS DRIVE
CITY: MELVILLE
STATE: NY
ZIP: 11747
BUSINESS PHONE: (631) 760-8100
MAIL ADDRESS:
STREET 1: 40 MARCUS DRIVE
CITY: MELVILLE
STATE: NY
ZIP: 11747
FORMER COMPANY:
FORMER CONFORMED NAME: Stem Cell Assurance, Inc.
DATE OF NAME CHANGE: 20101110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clyde Mandy D.
CENTRAL INDEX KEY: 0001527239
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37603
FILM NUMBER: 17964204
MAIL ADDRESS:
STREET 1: STEM CELL ASSURANCE, INC.
STREET 2: 555 HERITAGE DRIVE
CITY: JUPITER
STATE: FL
ZIP: 33458
FORMER NAME:
FORMER CONFORMED NAME: Clark Mandy D.
DATE OF NAME CHANGE: 20110802
4
1
doc1.xml
FORM 4
X0306
4
2017-07-12
0
0001505497
BioRestorative Therapies, Inc.
BRTX
0001527239
Clyde Mandy D.
40 MARCUS DRIVE
MELVILLE
NY
11747
0
1
0
0
VP of Operations
Stock Option
4.7
2010-12-15
2020-12-14
Common Stock
4000
4000
D
Stock Option
4.7
2021-04-20
Common Stock
300
300
D
Stock Option
4.7
2022-02-09
Common Stock
1500
1500
D
Stock Option
4.7
2022-12-07
Common Stock
2500
2500
D
Stock Option
4.7
2023-10-04
Common Stock
4000
4000
D
Stock Option
4.7
2024-02-18
Common Stock
6250
6250
D
Stock Option
4.7
2024-10-23
Common Stock
10000
10000
D
Stock Option
4.7
2025-09-04
Common Stock
25500
25500
D
Stock Option
3.73
2026-06-10
Common Stock
40000
40000
D
Stock Option
2.8
2017-07-12
4
A
0
30000
0
A
2027-07-12
Common Stock
30000
30000
D
The option is exercisable to the extent of 100 shares on each of April 21, 2011, April 21, 2012 and April 21, 2013.
The option is exercisable to the extent of 750 shares on each of February 10, 2012 and February 10, 2013.
The option is exercisable to the extent of 1,250 shares on each of December 7, 2012 and December 7, 2013.
The option is exercisable to the extent of 2,000 shares on each of October 4, 2013 and October 4, 2014.
The option is exercisable to the extent of 2,084 shares on February 18, 2014, and 2,083 shares on each of February 18, 2015 and February 18, 2016.
The option is exercisable to the extent of 3,334 shares on October 23, 2015 and 3,333 shares on each of October 23, 2016 and October 23, 2017.
The option is exercisable to the extent of 8,500 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018.
The option is exercisable to the extent of 13,334 shares on June 10, 2017 and 13,333 shares on each of June 10, 2018 and June 10, 2019.
The option is exercisable to the extent of 10,000 shares on each of July 12, 2018, July 12, 2019 and July 12, 2020.
/s/ Mandy D. Clyde
2017-07-13